These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 3038035)

  • 1. [Attempts to improve hybridoma technology for the production of human monoclonal antibodies].
    Tokunaga T; Chiba J; Ohnishi K
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2198-204. PubMed ID: 3038035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A strategy for the production of human monoclonal antibodies].
    Chiba J
    Hum Cell; 1988 Mar; 1(1):31-6. PubMed ID: 2856441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Monoclonal antibodies produced by human-human hybridomas].
    Chida J
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):157-64. PubMed ID: 6607711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renewal of EBV-hybridoma method: efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells.
    Ainai A; Kawase T; Ida A; Maeda Y; Ohba H; Ikeda Y; Sato H; Takahashi M; Chiba J
    Hum Antibodies; 2006; 15(4):139-54. PubMed ID: 17522436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human monoclonal antibody to purified protein derivative of tuberculin produced by hybrids constructed with Epstein-Barr virus-transformed B lymphocytes and mouse myeloma cells.
    Garzelli C; Puglisi C; Falcone G
    Eur J Immunol; 1986 May; 16(5):584-7. PubMed ID: 3009205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hybridization of EBV-immortalized human B-lymphocytes with a human-mouse heteromyeloma cell line.
    Jahn S; Walper A; Grunow R; Heym S; Volk HD; von Baehr R
    Allerg Immunol (Leipz); 1990; 36(4):359-65. PubMed ID: 1965878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A strategy for the production of human monoclonal antibodies reactive with lung tumor cell lines.
    Cole SP; Campling BG; Louwman IH; Kozbor D; Roder JC
    Cancer Res; 1984 Jul; 44(7):2750-3. PubMed ID: 6327024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of human anti-rubella monoclonal antibodies from human hybridomas constructed with antigen-specific Epstein-Barr virus transformed cell lines.
    Hilfenhaus J; Kanzy EJ; Köhler R; Willems WR
    Behring Inst Mitt; 1986 Jun; (80):31-41. PubMed ID: 3019293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of human-human hybridomas secreting antibody to sheep erythrocytes after in vitro immunization.
    Strike LE; Devens BH; Lundak RL
    J Immunol; 1984 Apr; 132(4):1798-803. PubMed ID: 6699402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPAM-8, a mouse-human heteromyeloma fusion partner in the production of human monoclonal antibodies. Establishment of a human monoclonal antibody against cytomegalovirus.
    Gustafsson B; Jondal M; Sundqvist VA
    Hum Antibodies Hybridomas; 1991 Jan; 2(1):26-32. PubMed ID: 1651784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the optimal human cell lines for development of human hybridomas.
    Abrams PG; Knost JA; Clarke G; Wilburn S; Oldham RK; Foon KA
    J Immunol; 1983 Sep; 131(3):1201-4. PubMed ID: 6350451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of antibody-producing cell lines by Epstein-Barr virus.
    Viallat JR; Kourilsky FM
    Pathol Biol (Paris); 1982 Apr; 30(4):232-42. PubMed ID: 6283460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte surface marker expression on hybridomas secreting human monoclonal antibodies.
    Seifert M; Jahn S; Schwab J; Döcke W; Volk HD; von Baehr R
    Hum Antibodies Hybridomas; 1992 Apr; 3(2):86-92. PubMed ID: 1633269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of antigen-specific human monoclonal antibodies from in vitro-primed human splenocytes.
    Boerner P; Lafond R; Lu WZ; Brams P; Royston I
    J Immunol; 1991 Jul; 147(1):86-95. PubMed ID: 2051030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of human monoclonal antibodies derived from lymphocytes of patients with cancer.
    Cote RJ; Morrissey DM; Oettgen HF; Old LJ
    Fed Proc; 1984 Jun; 43(9):2465-9. PubMed ID: 6327400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A human hybrid myeloma for production of human monoclonal antibodies.
    Kozbor D; Tripputi P; Roder JC; Croce CM
    J Immunol; 1984 Dec; 133(6):3001-5. PubMed ID: 6092464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of human monoclonal IgG and IgM antibodies with anti-D (rhesus) specificity using heterohybridomas.
    Thompson KM; Melamed MD; Eagle K; Gorick BD; Gibson T; Holburn AM; Hughes-Jones NC
    Immunology; 1986 May; 58(1):157-60. PubMed ID: 3011653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human-human B cell hybridomas from in vitro stimulated lymphocytes of patients with common variable immunodeficiency.
    Denis KA; Wall R; Saxon A
    J Immunol; 1983 Nov; 131(5):2273-8. PubMed ID: 6313803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporation of T cell counterparts in the fusion partners for generation of human monoclonal antibodies from Staphylococcus aureus stimulated B lymphocytes.
    Gore MM; Singhania SS; Basu A; Banerjee K
    Hum Antibodies; 1997; 8(1):26-32. PubMed ID: 9265502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.